Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Natus reopens Seattle plant after FDA warning

This article was originally published in Clinica

Executive Summary

Diagnostics specialist Natus Medical has resumed production and shipping at its Seattle, Washington manufacturing site after the site was shut down due to an FDA warning earlier this year. The company's Olympic Medical facility, which manufactures and distributes diagnostic technology for newborn care and sleep disorders, was subject to an FDA inspection in April 2007 and received a warning letter concerning "process deficiencies" in October. It was voluntarily closed on November 1 and remained inactive for nearly a month.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT050344

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel